pirfenidone has been researched along with Hermanski-Pudlak Syndrome in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akal, O; Akal, T; Barbu, A; Gahl, WA; Gochuico, BR; Introne, WJ; McGowan, MP; Merideth, MA; O'Brien, KJ; Seward, SL | 1 |
Hara, S; Harada, T; Ishimatsu, Y; Kakugawa, T; Kawabata, Y; Kohno, S; Miura, S; Mukae, H; Nakashima, S; Sakamoto, N; Tomonaga, M; Yoshii, C | 1 |
Roman, J; Santiago-Cornier, A; Vergne, Y; Vicary, GW; Young, LR | 1 |
Bernardini, I; Cardona, H; Gahl, WA; Gochuico, BR; Hess, R; Markello, TC; O'Brien, K; Salas, J; Troendle, J; Yao, J | 1 |
Celik, G; Ciledağ, A; Cirit Koçer, B; Kaya, A; Köktürk, N; Numanoğlu, N | 1 |
Avila, NA; Brantly, M; Calis, KA; Cardona, H; Gahl, WA; Gochuico, B; Montalvo, C; Padua, A; Troendle, J | 1 |
Azuma, A | 1 |
Liu, A; Troendle, JF; Wu, C; Yu, KF | 1 |
Antoniu, SA | 1 |
4 review(s) available for pirfenidone and Hermanski-Pudlak Syndrome
Article | Year |
---|---|
An autopsy case of Hermansky-Pudlak syndrome: a case report and review of the literature on treatment.
Topics: Adrenal Cortex Hormones; Autopsy; Ceroid; Drug Therapy, Combination; Fatal Outcome; Female; Hemorrhagic Disorders; Hermanski-Pudlak Syndrome; Humans; Immunosuppressive Agents; Lipofuscin; Lung Transplantation; Middle Aged; Pulmonary Fibrosis; Pyridones; Respiratory Insufficiency | 2014 |
Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.
Topics: Animals; Biomarkers; Disease Progression; Hermanski-Pudlak Syndrome; Hispanic or Latino; Humans; Indoles; Lung Transplantation; Membrane Proteins; Mice; Mutation; Puerto Rico; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed | 2016 |
[Expectation of new treatments for idiopathic interstitial pneumonias].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Clinical Trials as Topic; Hermanski-Pudlak Syndrome; Humans; Imatinib Mesylate; Interferon-gamma; Lung; Middle Aged; Piperazines; Prognosis; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Survival Analysis | 2005 |
Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Cell Line; Clinical Trials, Phase II as Topic; Connective Tissue Growth Factor; Cricetinae; Cyclophosphamide; Drug Evaluation, Preclinical; Drugs, Investigational; Fibroblasts; Hermanski-Pudlak Syndrome; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung Transplantation; Mice; Orphan Drug Production; Photosensitivity Disorders; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Scleroderma, Systemic; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
2 trial(s) available for pirfenidone and Hermanski-Pudlak Syndrome
Article | Year |
---|---|
Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis.
Topics: Adult; Female; Hermanski-Pudlak Syndrome; Humans; Male; Middle Aged; Patient Compliance; Pulmonary Fibrosis; Pyridones; Radiography; Treatment Outcome | 2011 |
Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome.
Topics: Adult; Double-Blind Method; Female; Hermanski-Pudlak Syndrome; Humans; Male; Middle Aged; Patient Compliance; Placebos; Pulmonary Fibrosis; Pyridones; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
3 other study(ies) available for pirfenidone and Hermanski-Pudlak Syndrome
Article | Year |
---|---|
Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis.
Topics: Adult; Aged; Female; Hermanski-Pudlak Syndrome; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis; Pyridones; Tomography, X-Ray Computed | 2018 |
A rare cause of interstitial lung disease: Hermansky-Pudlak syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dyspnea; Fatal Outcome; Hermanski-Pudlak Syndrome; Humans; Male; Middle Aged; Pulmonary Fibrosis; Pyridones; Radiography, Thoracic; Respiratory Insufficiency; Tomography, X-Ray Computed | 2011 |
Sequential testing for efficacy in clinical trials with non-transient effects.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Computer Simulation; Data Interpretation, Statistical; Female; Hermanski-Pudlak Syndrome; Humans; Male; Monte Carlo Method; Normal Distribution; Pulmonary Fibrosis; Pyridones; Vital Capacity | 2005 |